Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Hematologic Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Small Intestinal Neuroendocrine Tumor 1Papillomavirus Infections 1Pancreatic Adenocarcinoma 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Leukemia 1Heart Failure 1HER2-positive Breast Cancer 1Cystic Fibrosis 1Cardiomyopathies 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Echocardiography 4sacubitril and valsartan sodium hydrate drug combination 3Standard of Care 3Nutrition Assessment 3Exercise 3Electrocardiography 3Carvedilol 3dapagliflozin 2Surveys and Questionnaires 2Spironolactone 2Rituximab 2Lenalidomide 2Ivabradine 2Control Groups 2Blood Specimen Collection 2Atorvastatin 2Adrenergic beta-Antagonists 2ziprasidone 1pertuzumab 1pegfilgrastim 1obinutuzumab 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1acalabrutinib 1Zolpidem 1Watchful Waiting 1Warfarin 1Vincristine 1Vecuronium Bromide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Heart Failure × Electronic Health Records × Clear all
NCT05507879 2026-02-10

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

Mayo Clinic

Recruiting
200 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiomyopathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡